Related Experiment Videos
[Some aspects of the Clostridium difficile infection]
1Katedry i Kliniki Gastroenterologii Slaskiej Akademii Medycznej w Katowicach.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|September 28, 1998
Summary
Clostridium difficile infection, a common hospital-acquired enteric pathogen, ranges from asymptomatic cases to severe colitis. Antibiotics are a major risk factor, and treatment involves removing the cause and using specific antibiotics, though relapse is common.
Area of Science:
- Infectious Diseases
- Microbiology
- Gastroenterology
Context:
- Clostridium difficile is the leading cause of nosocomial enteric infections.
- Infections present a broad clinical spectrum, from asymptomatic carriage to severe colitis.
- Antibiotic therapy is a primary risk factor for C. difficile contagion.
Purpose:
- To outline the epidemiology, pathophysiology, and treatment of Clostridium difficile infection.
- To highlight the role of toxins A and B in disease manifestation.
- To underscore the challenge of relapse as a common complication.
Summary:
- The pathophysiology involves disruption of gut flora, spore ingestion, colonization, and toxin production (Toxin A and Toxin B).
- Treatment strategies focus on discontinuing causative agents and employing oral Vancomycin or Metronidazole.
- Relapse remains a significant challenge in managing C. difficile infections.
Impact:
- Improved understanding of C. difficile infection pathogenesis and risk factors.
- Informed clinical decision-making for treatment and management strategies.
- Highlights the need for further research into preventing and managing recurrent C. difficile infections.